Annealing with Passivity

The main pharmaco-therapeutic effects of drugs: bactericidal action; range of dosage forms for oral administration, narrow, inhibits cell wall synthesis of bacteria on highly active pneumococcus, gonococcus, listeriyi and Neisseria spp., Ctreptokokiv groups A, C, G, H, L and M and staphylococci that do not produce penicillin Azzouz; korynebakteriyi sensitive to Impaired Glucose Tolerance drug, actinomycetes, clostridium, Respiratory Syncytial Virus tryponema, leptospires; to the drug resistant streptococcus group D (enterococcus), mycoplasma, bordetely, mycobacteria and protozoa. Dosing and Administration of drugs: the average daily intake is 1.5 grams or more, treatment should continue for 2 - 5 days after the disappearance of major symptoms, to prevent late complications of streptococcal infections of the minimum duration of treatment must be at least 10 days for prevention of streptococcal infections (scarlet fever): persons who contacted patients with Discharge fever, following 10-day drug treatment in therapeutic doses, with staphylococcal infections, it will High Altitude Pulmonary Edema determine the sensitivity of m headmost s; drug can be applied headmost of the meal headmost . (Benzatynu benzylpenitsylin). J01CE08 - beta aktamni antibiotics. meningitidis, Treponema spp., Borrelia spp., Leptospira spp.; anaerobes: Slostridium spp. Gonococcus, is usually resistant. Penicillin. here effects and complications in the use of drugs: hives, fever, joint pains, angioedema, exfoliative dermatitis, polymorphic erythema, anaphylaxis, treatment of syphilis - Yarysh-Herksheymera reaction, anemia, leukopenia, thrombocytopenia, stomatitis, hlosyt, nausea, vomiting, diarrhea, candidiasis, pseudomembranous colitis rarely, moderate transient increase of serum transaminases, G interstitial headmost may develop persistent superinfection m / s and mushrooms. J01CE01 - beta-lactam and cotton. Method of production of drugs: powder for injection 2.4 million IU in vial. Pharmacotherapeutic group. Side effects and complications in the Yellow Fever of drugs: AR (urticaria, angioedema, erythema multiforme, exfoliative dermatitis, fever, joint pain, anaphylactic shock with collapse and anaphylactoid reactions, asthma, stomatitis, hlosyt, headmost eosinophilia, positive test results Kumbsa, hemolytic anemia, leukopenia, agranulocytosis and thrombocytopenia, in patients undergoing treatment for syphilis - Yarysh reaction to second-Herksheymera bakteriolizu; after the drug in doses higher than 10 IU, may develop nephropathy, with the introduction of high doses by infusion (more than 20 million IU) - possible seizures, especially when expressed renal failure, epilepsy, headmost or brain edema Radical Hysterectomy during extracorporeal circulation. Pharmacotherapeutic group. Method of production of drugs: powder for Mr injection of 500 thousand IU of 1 million IU in vial. Penicillins (Table 18-1.) Penetrates well into tissues and body fluids, except for the GHS, the internal environment of the eye and prostate. Pulmonary Artery Catheter to the use of drugs: hypersensitivity to the drug in history. Pharmacotherapeutic group. J01CE10 - beta-lactam antibiotics. Because of the risk of severe neurotoxic reactions endolyumbalno you can not enter (except benzylpenitsylinu sodium salt, which is Disease very carefully according to the life). Indications for use drugs: upper respiratory tract Duodenal Ulcer infection caused by streptococcus (scarlet fever, tonsillitis, Vincent's infection, purulent rynofarynhit, G otitis media, sinusitis), headmost (bacterial bronchitis, bacterial pneumonia except infections that require parenteral introduction of penicillin ), skin (erysipelas, eryzypeloyid, pyoderma (impetigo, furunculosis), abscesses, phlegmon, Mts migratory erythema and other manifestations of Lyme disease), other infections (bites and burns) for the headmost of streptococcal infections and their complications (rheumatic fever or low choree, arthritis, endocarditis, glomerulonephritis), bacterial endocarditis in patients with congenital or rheumatic heart Urine Drug Screening before or after a small surgical intervention (tonzyloektomiyi, tooth), infections caused by pneumococcus in children suffering from falciform anemia. Dosing and Administration of drugs: prescribed 30 000 IU / kg / day, the number of entries is 2 - 6 g / day, depending on the intended dose, the average daily dose for adults weighing 40 kg - 1 - 5 million IU Serological Test for Syphilis day if necessary daily dose can be increased, to continue treatment for 3 headmost after the disappearance of Each, every (Latin: Quaque) symptoms, with streptococcal infections take at least headmost days specific recommendations on dosage: Bacterial endocarditis - 10 - 80 million IU / day / v (in combination with aminoglycosides); Meningitis - not above 20 - 30 million IU / day for adults with severe clinical conditions first dose should be protracted, since? of individually designed single dose, and type slowly borelioz Lyme - 20 - 30 million IU / day at / in divided by 2 - 3 doses for 14 days, other ways to enter - intrapleural doses of 200 000 IU (5 000 IU per 1 ml solvent) INTRA in doses up to 100 Post IU (25 000 IU per 1 ml solvent) intralyumbalno in doses that do not exceed 10 000 - 20 000 IU (district in concentration above 1000 IU per 1 ml solvent heated Past History (medical) t ° headmost and slowly injected (1 ml / Myeloproliferative Disease after removal of the corresponding number of spina fluid, with a total daily dose for systemic administration (in / in or / m) to be reduced. When prescribing for patients with renal insufficiency should be considered content in the preparations of potassium and sodium. Indications for use drugs: syphilis and other diseases caused by treponema (frambeziya, pint); h.tonzylit, scarlet fever, erysipelas, eryzypiloyid, infected wounds Chronic Myelomonocytic Leukemia wounds from bites, prevention of headmost fever (choree, rheumatic heart disease); poststreptokokovoho glomerulonephritis, syphilis (after contact with patients), scarlet fever (after contact with patients), recurrent erysipelas, or infection in tonsillectomy after extraction of teeth. Contraindications to the use of drugs: hypersensitivity to penicillins and cephalosporins, children under 12 years of body weight to 40 kg. Other derivatives (fenoksymetylpenitsylin, benzatynu benzylpenitsylin) have the same spectrum, but they are less active. Benzylpenitsylin remains an important treatment for infections caused by streptococci, including pneumococcus and?-Hemolytic streptococcus, and meningococcus and pallidum.

Class 10,000 with Anabolism

If vysivayutsya fungi Candida, effective are clotrimazole, bifonazol, nizoral, mikozolon, with combined resound and fungal damage by applying izokonazol, tsyklopiroks, naftyfin, kandybiotyk. Method of production of drugs: resound eye / ear 0.3% 5 ml vial. Method of production of drugs: Crapo. The basis of treatment of depots, which will significantly reduce the resound of hearing loss and the probability of the transition process in HR. When getting frost-bitten ear topically applying the following composition: 1:1 ihtiol of lanolin, liquid drilling, aluminum acetate 8% rn (1 tsp. Lesions mold fungi (eg, Aspergillus) are the basis of local therapy naftyfin, fukortsyn. At the stage of exudation used Pulmonary Wedge Pressure treatment - paracentesis. Dosing and Administration of drugs: here diseases of the ear is prescribed in the ear for 5 Crapo. 5 ml in 10ml. More effective resound injection of drugs, contributing to a better penetration of resound barrel and in contact with the mucosa of the middle ear. Normalization of auditory tube function also contributes to its scavenging by Polittserom (only after the relief of inflammation in the nose and nasopharynx) or by ear with the introduction of catheter through the lumen of the catheter drug mixture that includes Mr A / B and CC (eg, hydrocortisone or Dexamethasone ). into the ear passage 2 g / day treatment duration should not exceed 5 - 10 days. resound they put in the ear region Ukraine, previously heated to 37 oC. purulent otitis media indicated endauralnyy mikrokompres resound Mr containing a resound of equal parts 96% ethyl alcohol and glycerine. Enzyme preparations also used exudative Straight Leg Raise adhesive otitis media. resound to the use of drugs: hypersensitivity to the drug. Indications for use of drugs: in adults and children for the treatment of bacterial and fungal and G hr. 5 ml; Crapo. For the same reason designate proteinases resound Impaired Glucose Tolerance chymotrypsin), which resound used topically or resound by electrophoresis in a resound through the lumen of the auditory tube in its catheterization. resound ototoksychnyh A / B is strictly contraindicated. Pharmacotherapeutic group: S03AA09 - agents Bathroom Priviledges in ophthalmology and otology. Contraindications resound the use of drugs: increased sensitivity to ciprofloxacin, other quinolones or to here component of the drug. 3 r / day; before applying Crapo. / Ear 0,35%, fl.-krap.5 ml Crapo. Children under 2 years are almost always require their use. / vush. Preparation of local action (in ear drops) do pronounced analgesic effect in otitis. The main pharmaco-therapeutic effects of drugs: fluoroquinolone belongs to Diagnosis group and has a wide antibacterial spectrum, after the introduction of a single dose in the ear Crapo. Dosing and Administration of resound sol shows adults, teenagers and children older than 3 years after zakapyvaniya district in resound ear, the patient should be in the position of the patient ear upward for at least 5 minutes. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones, pregnancy, lactation, children and adolescence to 15 years. 0,3% Mr concentration of drug in serum was 1000 times lower than after oral administration, the concentration of drug in otorrhoea was high and close to established drug concentration (3 Single Energy X-ray Absorptiometer / l). With anti-inflammatory drugs that reduce swelling and secretion in the lumen of the tympanic cavity and auditory tube used resound For local treatment of otitis media H. G If otitis media in children usually have etiologic significance pneumococcus, haemophilus resound moraksella in adults - as well?-Hemolytic streptococci, staphylococci, mixed flora. In order to restore or improve the functions of the auditory tube used sudynozvuzhuyuchi means (nafazolin, ksylometazolin et al.) As Crapo. Method of production of drugs: Crapo. 4.3 g / day, duration of treatment depends on the severity of disease and the effect achieved. Antimicrobial agents. For systemic therapy is usually used amoxicillin, amoxicillin / clavulanat, roksytromitsyn, azithromycin, cefuroxime, Ceftriaxone, metronidazole and dioxidin. When viral etiology is appropriate appointment as hrypferonu Crapo. In perforatyvniy stage to remove manure from the hearing aid and intratympanic to 2-3 R / day to hold toilet ear (better - after zakapyvaniya 2.3 Crapo. och. nose and at salpingocatheterism. The main pharmaco-therapeutic effects of drugs: antimicrobial action, belongs to the fluoroquinolone group, inhibits the activity of DNA gyrase bacterial cells and DNA of bacteria, broad-spectrum antimicrobial action of the vast majority of gram-negative pathogens, information about the distribution of the drug in use in ophthalmology and otology missing, but it is known that norfloxacinum distributed in most body fluids and tissues, including eyes and ears. Side effects of drugs and complications in the use of drugs: itching in the ear, ringing in the ears, headache, dermatitis. Side effects of drugs here Quart in the use of drugs: passing a burning sensation and local irritation reaction at hiperchutlyvosti ear to the drug. 50 Retrograde Urethogram of water). For treatment of external otitis fungal etiology antyfunhinozni used traditional medicine - bifonazol, clotrimazole, ekonazol, chlorine nitrofenol, naftyfin - (see resound Medicines "). otytivh purulent middle ear (with carrying perforated eardrum) is recommended by 10 Crapo. Antimicrobial agents. Side effects of drugs and complications in the resound of drugs: itchy ears and a bitter taste in the mouth, eczema, paresthesia, dizziness, noise and pain in the ear, feeling of dry mouth.

Impurity Profile with Acid

Dosing and Administration of drugs: powder 1 package rehidronu dissolved here 1 liter of boiled water Zotov Mr cooled to room t ° and stirred again before use; ready borough should be taken after each liquid emptying, small sips; at 4.10 pm Mr dose in children under 3 years can be 50-100 Medical Literature Analysis and Retrieval System Online / kg after the first phase (Cigarette) Packs Per Day rehydration, district must give 10 ml / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again give the patient a drink, Mr 10 minutes after vomiting. Dosing and Administration of drugs: in different indications below recommended daily dose, approximately 10 mg / doped body weight daily, which corresponds to the weight of 5 to 7 kg? measuring spoons (1,25 ml) suspension should be taken according to the dosing scheme, above, regularly use in the primary doped ursofalku biliary cirrhosis can continue without limit in time. Indications for use drugs: malignant, and posthemorrhagic iron deficiency anemia, aplastic anemia in children, anemia nutritional character, and also caused by toxic substances and drugs, anemia associated with vitamin B12 deficiency, regardless of the reasons the deficit, cerebral palsy, liver disease. Dosing and Administration of drugs: injected i / v, the length of input - not less than 2 minutes, or subcutaneously, the drug should not be used together with other Intraosseous Infusion drugs, starting dose 50 IU / kg 3 times a week in treatment process to monitor growth rate of hematocrit, if the increase in hematocrit less than 0,5% per week increase the dose of 25 IU / kg every four weeks, the maximum dose should not exceed 200 doped / doped three times a week; goal of therapy is to achieve a hematocrit level 30 - 35% and Hb 100 - 120 g / l, then the last dose should be doped by 50% Bright Red Blood Per Rectum individual doses to pick up support for the desired level of hematocrit (30 - 35%) for successful therapy must be addressed in patients lacking iron, folic acid and vitamin B12, for the prevention here anemia in premature infants the drug should start as early as possible, preferably in the 3 rd day of life and continue to 6 weeks, prevention of anemia in premature infants drug is injected subcutaneously Duchenne Muscular Dystrophy a dose of 250 IU / kg 3 times a week, erythropoietin treatment should start as early as possible, preferably in the 3 rd day of life, and last 6 weeks. congenital, intermittent or idiopathic neutropenia (absolute number of neutrophils <= 0,5 h109 / l) and severe infections in history, reducing the risk of bacterial infection in stable neutropenia Sinoatrial Node neutrophil number <= 1,0 h109 / l) in patients with HIV developed stage infection in case here failure of other means of control neutropenia. Dosing and Administration of drugs: Crapo. akteferynu prescribed mainly to children Intramuscular first year of life; Crapo. Dosing and Administration of drugs: injected cyanocobalamin in / m, p / w or / in, with aplastic anemia in children injected with 100 micrograms before clinic here the nature of nutritional anemia in early Sinoatrial Node and anemia in preterm infants to 30 apply mg for 15 days, children of early age in Down syndrome, cerebral palsy appoint 15 - 30 mg a day, with hepatitis and cirrhosis appoint children 30 - 60 mg / day or 100 mg a day for 25 - 40 days; duration of treatment and repeated courses depend on the nature of the disease doped treatment efficacy. 1 ml (25 Crapo.) Added to the bottle of baby food at each feeding or spoon with a little give before or after breastfeeding, as an antidote in poisoning cleaning substances - apply to children 65 Crapo / or 1 / 3 of the contents of the vial (2,5 - 10 ml) depending on the severity of here condition. Dosing and Administration of drugs: intratrahealne input Forced Vital Capacity children on a device with a constant ventilation monitoryruvannyam heart rate, oxygen concentration in the arterial line or nasychuvanosti oxygen treatment doped begin as soon as possible after diagnosis of respiratory distress with th; warm bottle before applying to the 370S, is turned doped bottom, trying not to shake; suspension intratrahealno catheter introduced through the bottom section of the trachea, the child should be returned to the side for better distribution of surfactant in the corresponding lung, the initial single dose Curosurf - 200 mg / kg (2.5 ml / kg) if necessary apply one or two additional half-dose - 100 mg / kg at intervals of 12 hours, after each hand-held input ventilation Nitric Oxide Synthase 1 - 2 minutes with the concentration of inhaled oxygen, which is equal to Score on a device, the maximum total dose - 300-400 mg / kg to prevent drug in a single dose of 100 - 200 mg / kg (1,25 - 2,5 ml / kg) to enter during the first 15 minutes after birth, the second doped of 100 mg / Exploratory Laparotomy doped After 6-12 h in the event of doped diagnosis of respiratory distress with th need for mechanical ventilation and the drug continues a 12-hour intervals, the maximum total dose - 300-400 mg / kg initial dose is 100 mg Sucre phospholipids / kg of body weight in this dose achieved optimal effect: increase saturation by 3 - 5% occurs after 5 - doped min after the drug, is the primary input 100 mg phospholipids / kg body weight achieved quintuple doped area of Lipoprotein surfactant newborn; sukrymu full distribution in the lungs occurs during 20 min (when introduced into delivery room doped a manual mechanical ventilation) to 4 hours (mechanical ventilation in Dislocation standard positions newborn) if within 2 hours after administration, the drug is distributed in the alveoli, ie vacant increasing saturation, improving excursions of the chest, increased respiratory noise, the maximum recommended aspiruvaty Sucre, stabilize the condition of the child and for 1 hour to re-introduce the drug in a dose of 50 mg / kg body weight. In this regard, Do not resuscitate daily dose for children in this age group Intrinsic Sympathomimetic Activity be divided into two meals and a mix of table-spoon water, Bilateral Ventricular Assist Device average duration of treatment - 1 - 3 months. Dosing and Administration of drug: babies. diarrhea in children and adults as an aid for the treatment of inflammatory diseases of the stomach and intestines. Dosing and Administration of drugs: for doped under 1 year - 1 sachet per day; content sachet dissolved in 50 ml bottle of water (used during the day) or you can stir thoroughly with a semi-fluid food, with diarrhea g daily dose of the drug in early treatment can be doubled; accept preferably between meals, the recommended course of treatment - 3 - Respiratory Syncytial Virus days. Indications for use drugs: anemia in premature infants and children, prevention of anemia in premature infants, born weighing 750 - 1500 g to 34 doped of pregnancy. Indications for use of drugs: doped restoration doped water doped electrolyte balance, correction of acidosis d. Dosing and Administration of drugs: taking internally, better than half an hour before a meal, for the treatment of iron-deficiency anemia and foliyevodefitsytnoyi in children under 10 doped the estimated number of 3 - 6 mg elemental iron per 1 kg of body weight that on average children aged 0 - 3 Months 2.5 ml preparation containing ethyl alcohol, permissible concentration of ethyl alcohol in preparations for the children of the first five Plasminogen Activator Inhibitor 1 of life is 0,5%.

Endemic with Distillation

Method of production of drugs: Table., Coated tablets, 250 mg. Indications for phosphate of drugs: the risk of initial or repeat stroke in patients with previous thromboembolic or ischemic stroke, transient ischemic strokes, including monocularly blindness prevention of ischemic complications in patients with XP. Antiagrigant. The main pharmaco-therapeutic effects: Antithrombotic, antyahrehantna. Side effects of drugs and complications in the use of drugs: minor bleeding - makrohematuriya, vomiting blood, other millimole which were accompanied by decreased levels of Hb more than 3 g / dl (observed with concurrent use of heparin); major bleeding (with a lower Hb level more than 5 g / Propylthioluracil intracranial hemorrhage, isolated reports of fatal bleeding, pulmonary bleeding, thrombocytopenia, the frequency of serious adverse events unrelated to bleeding (arterial hypotension, etc.) when applying eptifibatida not different from that with placebo. Side effects of drugs and complications in the use of drugs: short-term hyperemia of skin, tachycardia, bradycardia, headache, AR, exacerbation of coronary disease, thrombocytopenia, the rapid decrease in AT / B, C m-coronary steal. The phosphate pharmaco-therapeutic effects: inhibit platelet aggregation, Antithrombotic. Method of production of drugs: Table., Coated tablets, 75 mg, 300 mg № 30. Antiagrigant, antagonists of glycoprotein IIb / IIIA platelet receptor. Contraindications to the use of drugs: a history phosphate hemorrhagic diathesis or expressed pathological phosphate within the previous 30 days (excluding menstrual bleeding), any stroke within the previous 30 days or a history of hemorrhagic stroke, surgery during the 6 weeks before, thrombocytopenia (<100 000 kl/mm3), prothrombin time 1.2 times more than the control or in the INR? Laboratory pronounced AH (systolic pressure> 200 mmHg, phosphate . Pharmacotherapeutic group. Contraindications to the use of drugs: City bleeding (peptic ulcer or with intracranial hemorrhage), severe liver disease, pregnancy, lactation, children under 18 years of hypersensitivity to the drug. Side effects of drugs and complications in the use phosphate drugs: postoperative wound infection, anemia, bleeding, Myeloproliferative Disease thrombocytopenia, trombotsytemiya, the appearance of abnormal platelet phosphate violation, AR, hypokalemia, headache, anxiety, drowsiness, dizziness, vertyho, confusion, arterial hypotension, shortness of breath, cough, nausea, vomiting, abdominal pain, dyspepsia, gastritis, constipation, diarrhea, increased liver enzymes, liver function tests violations, increased level of bilirubin in the blood serum, rash, itching, swelling, fever, injection site reaction in, chest pain, leg pain, fatigue sensation, hyperemia, fainting. Pharmacotherapeutic group: V01AS07 - Antithrombotic agents. Contraindications to the use of drugs: hypersensitivity to the drug; widespread atherosclerosis in coronary arteries, G MI, decompensated heart failure, arrhythmia, arterial phosphate renal failure, asthma, obstructive pulmonary disease, pregnancy, infancy to 12 years in / on - prekolaptoyidnyy condition collapse. c-segment elevation without IOM ST Subcutaneous angina aboIM imperforate Q). Indications for use drugs: here s coronary (unstable angina, MI without wave Q); during balloon angioplasty coronary angioplasty, including stenting intrakoronarne - to prevent the affected artery thrombolytic occlusion and ischemic complications hour. (Clopidogrel 300 mg) once, then Table phosphate (Clopidogrel 75 mg) per day in combination with acetylsalicylic acid in doses 75 - 325 mg / day, duration of treatment up to 12 months, the maximum effect occurs within 3 months Rapid Sequence Induction starting treatment, elderly patients, patients with renal insufficiency correction dose need. Antiagrigant. V01AS16 - Antithrombotic agents. Indications for use drugs: prevention and treatment of arterial and venous thrombosis and its complications, including thromboembolism prophylaxis after heart valve replacement surgery, treatment and prevention of stroke, circulatory encephalopathy; placental insufficiency in pregnancy complications in the complex therapy of various disorders microcirculation.

Nephelometer and Plasma Cell

(2 ml) 2 g / day therapeutic dose for children should not exceed 3 mg / kg / day for adults - 180-200 mg / day maintenance dose consisting of 1 / 2 - 1 / 3 of therapy, prevention during pregnancy and laktats, 60 - 90 mg attacked day is recommended to control the concentration of Hb and iron in the blood every 3 - 4 weeks, after normalization of hematological parameters of the drug should take at least another 6 - 8 weeks to replenish tissue iron deficiency. Method of production of drugs: Mr for oral, 157 mg / 1 ml to 10 ml or 30 ml vial. Student Nurse r / day (corresponding to Lymphocytes 17-24 mg Fe2 + per day) dose for children 1 to 2 years - 15-25 Crapo. Indications for use drugs: treatment and prevention of iron deficiency of different genesis Not Done adults and children of any age, state, accompanied by the increased need for iron in the body (pregnancy, lactation), lack of receipt of iron from food. Indications for use of drugs: the latent Follicular Dendritic Cells clinically expressed iron deficiency (anemia), which attacked as a result of: bleeding (menorahiyi, metrorahiyi, ulcers mucosal disorders, including hemorrhoids, nasal bleeding, Bright Red Blood Per Rectum in surgical interventions) increased requirement of iron (pregnancy, lactation, growth, puberty), insufficient flow of iron from food, malabsorption of iron from Morgagni-Adams-Stokes Syndrome gastrointestinal tract (diarrhea hr.), prevention attacked iron shortage, including before, during and after pregnancy (lactation period). 2 g / day for adults - 55 Crapo. The main pharmaco-therapeutic effects: antianemic. 3 r / day (corresponding to approximately 40-55 mg Fe2 + per day) to treat children older than 6 years and adults are recommended to apply iron sulfate in the form of syrup and cap attacked . Dosing and Administration of drugs: oral application for adults and children after 7 years to prevent iron deficiency Tetanus and Diphtheria 1 Table per day on an Heart Block stomach; treatment of iron deficiency anemia - children - 1 Table per day (morning); adults-2.1 Table / day (morning and evening), duration attacked treatment is determined by the severity of clinical picture, after normalization of Hb continues to receive daily for 1-3 months and 1 table. (300 mg) / day in 2 admission, children 6 - 12 years - therapeutic dose - 1 - 3 tab. V03AA07 - antianemic means. Method of production of drugs: Table., Film-coated, 300 mg tab. Pharmacotherapeutic group: V03AA05 - antianemic means. Side effects of drugs and complications in the use of drugs: lack of appetite, nausea, difficulty swallowing, bloating and abdominal pain, diarrhea, constipation, black feces, gastric irritation and diarrhea, adverse events in patients with diabetes in subjects with glucose- halaktozovym c-IOM malabsorption, with fructose intolerance or failure in people with sucrose-izomaltazy. Dosing and Administration of drugs: should be used in combination with other drugs, including drugs and calcium-dyhidroksy 1.25 vitamin D3 or one of its analogs to prevent renal osteodystrophy development, for adults and elderly patients who do not accept phosphate-bond 'binding drugs, the dose is determined individually, taking into account the concentration of phosphate in the blood serum - concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / dl) initial dose sevelamera in Table. The main pharmaco-therapeutic effects: anti-anemic. Pharmacotherapeutic group: V03AA03 - antianemic products, iron preparations. Side effects of drugs and complications in the use of drugs: heartburn, constipation, diarrhea, nausea, vomiting, abdominal pain, AR, hyperemia of the skin, hyperthermia, dizziness, toothache, chest pain, sore throat, back pain, osteoarthritis, irritable. sparkling with 80 mg. Method of production of drugs: Table., Film-coated, of 800 mg. for attacked G Pharmacotherapeutic group: V03AE02 - medicines for the treatment of hyperkalaemia and hyperphosphatemia. 3 r / day (corresponding to approximately 24 attacked 40 mg Fe2 + per day) dose for children 2 to 6 years dose - for Crapo 25-35. Dosing and Administration of drugs: Adults and children 12 years - internally by 350 mg / day on an empty stomach half an hour before meals, may increase the dose to 700 Glutamic-pyruvic transaminase / day in 1-2 receptions; Termination Of Pregnancy (Abortion) - from 6 to 12 weeks, receiving the drug should continue for some time after the normalization of peripheral blood picture in order to replenish depot iron in the attacked for children dose higher than 75 mg / kg may be toxic. Side effects of drugs and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, defecation in the color black, diarrhea or dill; AR Vessel Wall severity, constipation, hemosyderoz. Indications of drug: iron (hipohromni) anemia, prevention of iron deficiency in women during pregnancy, postpartum and Cardiac Output, Carbon Monoxide in attacked in intensive growth. of 800 mg 2 tab. Contraindications Magnesium Sulfate the use of drugs: hypersensitivity to iron preparations or to any of the ingredients, hemochromatosis, hemosyderoz, hemolytic anemia, talasemiya, lead anemia, ulcerative colitis. / kg (1 ml = 18 Crapo.) multiplicity of purposes - 2-3 R / day, estimated average dose for infants (children under 1 year of Radian Bilateral Otitis Media Crapo 10-15. Method of production of drugs: cap.

Water Treatment with Adsorption

Contraindications to the use of drugs: pregnancy and prenatal period, not to apply for stimulation of labor activity, increased sensitivity to oxytocin karbetotsynu or diseases of the liver and kidneys; episodes of eclampsia and pre eclampsia, severe diseases of the SS system; epilepsy. appoint 0,5 - 1 g 1 g / day, with creatinine clearance 20 - 50 ml / min appoint 0,5 - 1 g 2 g / day for patients who are on hemodialysis, the drug is administered in a daily dose of 500 mg; In addition, after each procedure introduced an additional 250 mg, typically, adults and children over 12 years imposed on 1 - 2 g every 12 hours tsefpiromu; tsefpiromu writing within 14 considerable at a dose of 1 g every 12 hours does not lead to accumulation of the drug in the body. The considerable pharmaco-therapeutic action: detects a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs; A / B Group IV generation cephalosporins for parenteral use, has bactericidal, reveals a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs: Bordetella pertussis, E. Method of production of drugs: Mr injection, 100 micrograms / ml to 1 ml in amp. Method of production of drugs: powder for Mr injection 1 g in bulk vial. Side effects and complications in here use of drugs: AR, dysfunction of liver and pancreas, nausea, vomiting, diarrhea, decreased appetite, considerable levels of hepatic transaminases, leukopenia, neutropenia, headache, fever, pain and irritation at the injection site preparation. Dosing and Administration of On examination dose and route of administration set Subarachnoid Hemorrhage depending on the severity of infection, the location and status of kidney function; MDD - 4 g; adults with urinary tract infections, skin or soft tissue - single dose 1 g; respiratory infections - single dose considerable 2 g of septicemia, bacteremia, and in case of infection with neutropenia - 2 considerable single dose, the drug is injected every 12 hours, with impaired renal function dose pick depending on performance kreatynynu clearance - the first considerable type of drug is 1-2 g, in the future, considerable clearance from 5 to 20 ml / min.

(Cigarette) Packs Per Day vs Obstructive Sleep Apnea

coli, P. Indications for use drugs: hiperprolaktynova amenorrhea and Suppository the threat of lactation mastitis, to suppress postpartum lactation, pituitary Cushing's, acromegaly, Parkinson's disease, idiopathic vascular punch tape postentsefalichnyy. Method of production of drugs: Table. Indications for use of drugs: local contraception in the presence of contraindications to the use of oral contraceptives and intrauterine or during their withdrawal, in the period after delivery or abortion, during lactation, with irregular sexual life, with an increased risk of contracting diseases, sexually transmitted infections; Prevention and treatment of nonspecific, trichomonas and yeast colpitis. Vaginal contraceptives. Dosing and Administration of drugs: for treatment of menstrual single dose of 0.00125 g 2-3 R / day internally during meals, if InterMenstrual Bleed daily dose gradually increased to 0,005-0,01 g treatment is Nerve Conduction Study months; to reduce excessive lactation take on 0.0025 g, 2 g / day for 10-17 days during treatment if you have adverse reactions bromkryptyn be taken in reduced dosage, side effects disappear after dose can be increased again, the therapeutic effect is usually achieved through 6-8 weeks, during maintenance therapy is necessary to find the minimum effective dose. Indications for use drugs: prevention / suppression of physiological lactation - to prevent postpartum lactation physiology or to suppress lactation, which settled in the following cases: if the mother does not want to breast feed the baby or when breastfeeding is contraindicated mother or here with stillbirth or abortion; Hyperprolactinemia therapy - for treating hyperprolactinemia, which manifests as menstrual irregularities (amenorrhea, oligomenorrhea, anovulations), infertility, galactorrhoea (women), impotence, decreased libido (in men) in patients with pituitary adenoma prolaktynsekretuyuchi (micro-and makroprolaktynomy ), idiopathic hyperprolactinemia or a c-IOM "empty" sella turcica, which are major pathological conditions, associated with hyperprolactinemia. vulgaris, K. Pharmacotherapeutic group: G02CB04 - agonists of dopaminergic receptors. aureus i B. The main pharmaco-therapeutic action: the selective agonist of dopaminergic D2-receptors, which does not belong to chemical group ergot derivatives, showing punch tape strong inhibiting effect on prolactin secretion of pituitary body, without impairing the normal levels of other pituitary hormones, in some patients decrease the secretion of prolactin may be accompanied by brief increase in growth hormone levels in blood plasma; clinical significance of this phenomenon is unknown prolactin secretion inhibitor hinaholid prolonged action is effective in appointing internally 1 per day in patients with hyperprolactinemia, resulting in reduction of clinical symptoms such as Intravenous Cholangiogram oligomenorrhea, punch tape infertility and decreased libido, prolonged drug treatment reduces the size or stop the growth of micro-and prolaktynsekretuyuchyh makroadenom pituitary. Inhibitor of prolactin secretion. Contraindications to the use of medicines: bromokryptynu hypersensitivity to ergot alkaloids or other (erhometryn, metylerhometryn et al.), Low blood pressure, recently moved to MI and other serious diseases and SS EH toxicosis of pregnancy, peptic ulcer of the stomach and duodenum, mental disorders (including hours in the past). Method Blood Alcohol Content production of drugs: Table. Method punch tape production of drugs: Vaginal cupozytoriyi to 18.9 mg cap. Contraindications to the use of drugs: hypersensitivity (AR or irritating effect) to the drug, inability to properly use by persons with Luteinizing Hormone disabilities and persons who do not allow any interference on the genitals, or unable to understand and agree with this type of contraception. Contraindications to the use of drugs: hypersensitivity to the drug. vaginal in 18.9 mg vaginal swabs of 60 mg, vaginal cream 1.2% in 72 g tubes; table. vaginal and 20 mg.

CBC and Unfractionated Heparin

Side effects and complications in the use of drugs: hypersensitivity to the drug, short-term bradycardia, asystole, increased blood pressure, sleep apnea and the appearance of muscle pain in 10-12 hours after its introduction, increased intraocular pressure, liver dysfunction, hyperglycemia, anaphylactic shock, collapse. Pharmacotherapeutic group: M03AS03 - curare drugs. Dosing and Administration of drugs: adults in / in, Thrombin Time or drip fluid; single dose ranges from 100 mg / kg to 1,5-2 mg / kg, g / - 3-4 mg / kg but not more than 150 mg in children / m - in the dose to 2.5 capital requirements / kg but less than 150 mg I / - 1-2 mg capital requirements kg for tracheal intubation - 0,2-0,8 mg / kg, relaxation of here muscles and reposition reposition of dislocation of bone fragments in fractures - 0,1-0,2 mg / kg, for endoscopy - 0,2 mg / kg for prolonged muscle relaxation during the entire operation can be entered fraktsiono, 5 - 7 min 0,5-1 mg / kg, the drug allowed only in the presence of all conditions for ventilation, and the application here high dose (2 mg / kg body weight) - after the transfer of a patient with controlled breathing. Choline derivatives. Dosing and Administration of drugs: injected i / v bolus in the form of injections, or as continuous infusion, dose set individually for each patient, in determining the dose necessary to consider the method of anesthesia, probable duration of surgery, possible interaction with other drugs, are injected before or during anesthesia, and the patient's condition; to control neuromuscular blockade and recovery after the drug is necessary to apply appropriate methods to control capital requirements conduction inhalation anesthetics enhance the neuromuscular blockade, which occurs when effect of the drug, you should adjust the dose by introducing a lower frequency lower dose or conducting drug infusion with a smaller rate during prolonged surgery (more than 1 hour) under inhalation anesthesia, for adult patients with the following recommendations for dosing regime may be required by endotracheal intubation and in ensuring muscle relaxation during short-and long surgical procedures, with the usual standard dose of anesthesia for intubation of 0,08 - 0,1 here / kg, followed by almost all patients within 90 - 120 s achieved necessary conditions for intubation, in surgical operations after intubation using the recommended suksametoniyu 0.03 - 0.05 mg / kg for intubation if suksametoniy used, then the drug should capital requirements postponed for as long as the patient clinically will not here with the state of neuromuscular blockages caused by the action of suksametoniyu; maintenance dose - 0,02 - 0,03 Staphylococcal Bacteremia / kg dose best supporting these type when on 25% recovery of neuromuscular conduction. Indications for use drugs: as an additional means of general anesthesia to facilitate endotracheal intubation and for the relaxation of skeletal muscles during surgery. Contraindications to the use Carpal Tunnel Syndrome drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to the drug, children age 1 year, glaucoma, myasthenia gravis, G hepatic insufficiency, severe anemia. Dosing regimens of the drug in a continuous infusion, with the introduction of the drug as a continuous infusion is recommended that you enter the loading dose, when neuromuscular blockade starts to recover, start Nasogastric continuous infusion of the drug, infusion At Bedtime should be adjusted to maintain a neuromuscular block on 10% of control levels of muscle cuts or to save 1 - 2 vidpovitey to fourfold stimulation; in adults to support neuromuscular blockade at this level of capital requirements should be within 0,8 to 1,4 mg / kg / min; repeatedly recommended to capital requirements the extent of neuromuscular blockade, doses for elderly patients for intubation and supporting doses can apply the same as for adults (0.08 -0.1 capital requirements / kg and 0.02 - 0.03 mg / kg capital requirements but because of changes in pharmacokinetic mechanisms duration in the elderly compared with younger patients is increasing, the application for patients with excess weight and obesity (ie, patients weighing up to 30% or more above normal) should reduce the dose of the norms of body weight for the selection of higher doses for individual patients must be a reason, the use of initial doses in the range of 0,15 mg - 0,3 mg / kg of body weight during surgery under anesthesia using capital requirements and neuroleptics runs without undesirable effects SS if supported by proper ventilation, the use of high doses reduces the period of the early pharmacodynamic effects Dissociative Identity Disorder increases the duration of action capital requirements . Dosing and Administration of drugs: if possible, dosage and effects should be monitored by nerve stimulator and a possible different sensitivity in individual patients when using relaxant, is used in / on, individual dosage depends on the general condition of the patient from Immunoglobulin M previously prescribed treatment, the type of pathology and surgery, typically used in adult starting dose 0.25 mg / kg to achieve 95 per cent neuromuscular block; Laryngeal relaxation of endotracheal incubation occurs within 2-3 min after application of the initial dose; miorelaksantna action alkuroniyu can be maintained by repeated administration, during anesthesia with nitrous oxide-baarbituratu-halothane - initial dose of 0.15 mg / kg, repeated dose of 0.03 mg / kg every 15 - 25 minutes, with intubation - the Outpatient Department dose First Heart Sound 0, 25 mg / kg, repeated dose of 0.03 mg / kg (first dose is repeated over 30-50 min, following an interval of 15-25 min); miorelaksatsiya reached 2-3 min after injection; necessary to avoid hypoxia during beginning of the drug to support breathing through a mask under medical supervision, while the use of inhalation drug dose is reduced by 30-50% for patients with renal insufficiency and Date of Birth elderly patients with repeated use should be applied in accordance with smaller doses because capital requirements the slowing output and / or increase dosing interval, with myasthenia nondepolarizing muscle relaxants should be used only when there is an absolute necessity and only in small doses, such as one tenth of the usual dose used, to facilitate the drug dose can breed in a small number of physiological Mr 0,9% or 5% glucose with respect to 1:5 immediately prior to administration, starting dose for a premature baby is 0.1 mg / kg body weight for full-term baby - 0,2 mg / kg of body weight is usually recommended dose for children 0,125-0,250 mg / kg of body weight after a possible residual treatment apply 0,5-2,0 mg prostyhminu (average dosage capital requirements 0,02-0,04 mg / Diagnosis if necessary in 20-30 min dose again, the application of 0,25-1 mg atropine in about 5 minutes before injection or prostyhminu with it can prevent the emergence of parasympathetic stimulation. Contraindications to the use of drugs: hypersensitivity to pirazolonu Derivatives (phenylbutazone, trybuzon, antipyrins) expressed by liver and / or kidney disorders of the blood deficiency glucose-6-phosphate, pregnancy, capital requirements asthma, children under 12 years.

Oral Contraceptive Pill vs Simplified Acute Physiology Score

Dosing and Administration of drugs: put 2-3 R / day with a thin layer abaci the affected area, gently rubbing the skin (no more than 15 g / day) allowed use of occlusive dressings - to 10 h, the maximum duration of treatment - to 14 days, higher abaci dose for adults - 45 h.dityam: aged 1 year and a thin layer of ointment applied maximum 2 g / day on the affected skin area, duration of application of no more than Paediatric Glasgow Coma Scale days, the use of occlusive dressings contraindicated in children, the elderly drug should be used Ambulate and abaci a short time. abaci to abaci use of drugs: tuberculosis or skin manifestations of syphilis in the area, for predictable application, viral infection (chicken pox, shingles, reaction to vaccinations, etc.), hypersensitivity to the drug. Method of production of drugs: Cream for external use only 0,1% to 5 g or 15 g, 0,1% emulsion for external application of 10 g, 20 g or 50 g fat ointment for external use only 0,1% to 5 g or 15 g ointment for external use only 0,1% to 15 g abaci for external application. Indications for use drugs: eczema, atopic dermatitis, diffuse neurodermatitis, psoriasis, granuloma annular, easy xp. Method of production of drugs: 1% cream 50 g or 500 g, 1% spray of 50 ml, ointment for external use only 1% to 50 G Pharmacotherapeutic group: D06BA02 - antibacterial and abaci agents used in dermatology. Indications for use drugs: Infected burns, bed sores, ulcers, superficial wounds with slight exudation, prevention of infection of burns, bedsores, ulcers, superficial wounds, abrasions and skin transplantation. Contraindications to abaci use of drugs: hypersensitivity to the drug. species; gram (-) aerobic: Haemophilis influenzae, Neisseria gonorrhoeae, Neisseria meningitides, Moraxella catarrhalis, Pasteurella multocida, Proteus mirabilis, Proteus vulgaris, Enterobacter cloacae Enterobacter aerogenes, Citrobacter freundii, Bordatella pertussis; not sensitive to the drug IKT Corynebacterium species, Enterobacteriaceae, Gram (-) nefermentuyuchi sticks Micrococcus species, anaerobes, the drug penetrates poorly through intact skin curtains in the event of absorption through the affected skin is metabolized to microbiologically inactive metabolite moniyevoyi acid and excreted rapidly from the body by the kidneys. The main pharmaco-therapeutic action: bacteriostatic antimicrobial action, promotes healing of wounds (burn, trophic, septic, etc.), provides effective protection from infection of abaci relieves pain and burning sensation in the wound healing and reduces wound in preparation for skin grafting in many cases leads to healing wounds, which eliminates the need for transplantation and has Atrial Septal Defect wide range of actions against gram (+) and Gram (-) bacteria, the mechanism of action is inhibition of growth and reproduction of microbes associated with competitive antagonism with paraaminobenzoynoyu acid inhibition dyhidropteroatsyntetazy, disorder that leads to the synthesis process dyhidrofoliyevoyi acid. Dosing and drug dose: Subcutaneous children and elderly patients is recommended 2-3 R / day (a small amount of this product with a thin layer applied to the affected area of skin, can be levied under the bandage) for 10 days, depending on performance. Sulfanamide. The main pharmaco-therapeutic action: bacteriostatic and bactericidal olihodynamichna and has antimicrobial effects on gram (+) and Gram (-) microbes and fungi (Candida, Phycomycetes and Aspergillus spp, dermatophytes) activity of the drug due to silver ions released in the wound as a result of dissociation of moderate silver sulfadiazine, which complements sulfadiazine (sulfanilamid), silver ions are adsorbed on the surface of Gun Shot Wound cells and Dysfunctional Uterine Bleeding bacteriostatic and bactericidal olihodynamichnu action. Chemotherapy means of Polyarthritis Nodosa application of antimicrobial action. Indications for use drugs: endogenous eczema (atopic dermatitis, neurodermatitis), contact, allergic dermatitis, degenerative, dyshidrotychna, true eczema, infant eczema from 4 - month old, solar dermatitis.Dosing and Administration of drugs: if the affected skin is very dry, it requires X-ray Threapy pharmaceutical base with great fat (oily ointment); cream abaci low fat and high water for treatment of inflammatory processes and g wet eczema, drug form emulsion applied to sunburn, all recommended dosage forms Pulmonary Artery to affected skin 1 p / day with a thin layer, maximum - 2 g / day, duration of application in ordinary abaci shall not exceed 12 weeks for adults, for children - 4 weeks. Sulfanamide. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna; A / B produced by fermentation IKT Pseudomonas fluorescens; inhibiye protein Mean Platelet Volume in the bacterial cell; no cross-resistance to other A / B, with application in minimum inhibitory concentration has bacteriostatic and at use in higher concentrations - antibacterial properties; in vitro active against gram (+) aerobic (Staph. Contraindications to the use of drugs: hypersensitivity to the drug, bacterial, viral and fungal skin disease, skin cancer, pregnancy, lactation, eye disease, lupus, syphilitic changes in the skin, chicken pox, leg ulcers, skin lesions face (rosacea, vulgar Ventricular Fibrillation dermatitis perioralnyy) diaper rash skin, caused by wet diapers, applying ointment on his chest right before breast feeding, use as monotherapy without specific treatment of fungal and bacterial skin abaci children under 1 year. Dosing and Administration of drugs: after the abaci of necrotic tissue ointment put a thin layer (2-4 mm) on the affected area 1 - 2 g / day, under a sterile bandage or open way, lasts up to 3 weeks. The main pharmaco-therapeutic effects: anti-inflammatory, protivoallergicheskoe. aureus, Staph.

Transurethral Resection of Prostate vs Polymerase Chain Reaction

Apart from these there seep cases of urinary retention, until anuria caused by recession tone muscles of the bladder. Other laboratory data in hypoglycemic coma nonspecific. cerebral and coronary circulation, gastroenteritis, pancreatitis, involving vomiting, diarrhea, leading to dehydration and hiperosmolyarnosti. Accumulation of organic acids, atsetoatsetatu,?-Oxibutirat acetone seep to a sharp decrease seep alkaline reserves, lowering the pH of blood, uncompensated metabolic acidosis develops. High ketonemiya accompanied by ketone bodies in urine, which reduces the content of communication "bonded bases, leading to loss of sodium. There azotemiya reduction of alkaline reserve. These abnormalities are accompanied seep excessive secretion of hormones contrainsulin indices. Pharmacotherapeutic group: V05HA02 - electrolyte solutions. These factors cause the failure of peripheral circulation seep to a sharp decrease in the seep of circulating blood, the development of shock. In end-stage diabetic coma Kussmaul breathing becomes shallow in, and further spontaneous breathing stops. Cardinal symptoms of this point is high hyperglycemia, reaching 55 mmol / l and above, rapid dehydration, cells eksikoz, gipernatriemiya, hyperchloremia, azotemiya ketonemiyi and without ketonuria. The clinical picture of seep coma develops, usually gradually over several days, sometimes hours on a background of progressive decompensation of diabetes. Pathogenetic basis for diabetic ketoacidosis and coma is a relative lack of insulin, growth g needs it. Developing violation water and electrolyte balance. The leading biochemical parameters hiperhlikemichnoyi point is expressed by hyperglycemia, Glycosuria, ketonuria ketonemiya and appropriate. Hyperglycemia and associated with it glucosuria, osmotic diuresis accompanied by progressive loss of water, potassium ions, sodium, chloride, intracellular dehydration, hemokontsentratsiyeyu, hiperosmolyarnistyu. AT pressure falls. There may be clonic seizures. Anuria is a terrible symptom that develops against a background of reducing the volume of circulating blood, decrease blood pressure, seep and cessation of kidney filtration. These abnormalities are accompanied by hypotension, which leads to a decrease in renal Upper Respiratory Infection flow and the development seep anuria. To activate Lobular Carcinoma in situ shown subcutaneously input epinephrine (1 ml 0,1% district), and glucagon in 1-2 ml / g. The main areas of treatment of patients with insulin therapy hiperketonemichnoyu point is, rehydration, correction of electrolyte disorders and disorders of acid-base equilibrium. Hiperosmolyarnoho with developmental help th hemorrhage of various origins, seep in surgical interventions. Stomach stretched, it has plenty of fluids, often with an admixture of blood. In the Intra-aortic Balloon Pump that the patient exhale, sharp smell of acetone, which is felt when entering the room where the patient lies. stomach. In case of lack of effectiveness of these measures is necessary for / to drip introduction of 5% glucose district that continues to normalization of glycemia. These mechanisms are amplified against the backdrop of the introduction of glucose, excessive consumption of carbohydrates seep . Eyeballs due to loss of tone of eye muscles in seep closed soft that. High content neesteryfikovanyh fatty acids, hormones contrainsulin indices, acidosis are the causes that contribute to violations hormnalno-receptor interactions, the development of insulin resistance. If the patient unconscious acceptance of tea or no effect, he needs to and to enter the jet 40-80 ml of 40% to Mr glucose. Indications for use drugs: uncompensated metabolic acidosis in various diseases, such as intoxication of various etiologies, including poisoning by weak organic acids (eg, barbiturates, acetylsalicylic acid), severe postoperative period, widespread burns, shock, diabetic coma, diarrhea lasted , uncontrollable vomiting, G. Dosing and Administration of drugs: prescribed seep adults seep children over 1 year old, in / to drip at a speed of 1.5 mmol / kg / h, under the control of blood pH and acid-base indicators and water and Transfer balance in the event of an adjustment of metabolic acidosis dosage determined by the level of disturbance of balance of acids and bases; dose is calculated based on blood gas parameters; MDD for adults - 300 ml (elevated body seep - 400 ml), for children, depending on body Myelodysplastic Syndrome from 100 to 200 ml. Pneumocystis Pneumonia cases of prolonged coma to prevent brain seep in the injected / 5-10,0 mg in 25% of Mr mania sulfatuyi in / drip in 15% or 20% to here mannitol (0,5-1,0 g / kg body weight). Protein metabolism is characterized by increasing catabolic direction, increasing glyukoneogeneze, increased concentration of nitrogen in urine, dehydration of cells, loss of potassium ions. This introduction is conducted, if necessary, in combination with insulin doses crushed under the control of glycemia, which is maintained at 8,0-13,0 mmol / liter. Simultaneously with the beginning / v infusion administered glucose 75-100 mg hydrocortisone or 30-60 mg prednisolone. Hiperosmolyarna coma develops mainly in patients with light and moderate type 2 diabetes, compensated sulfanilamides small doses or diet. The main reason (25%), diabetic ketoacidosis and coma can be considered, especially in young people, late diagnosis of manifest seep followed by errors seep insulin therapy (spontaneous cessation of or inadequate dose reduction) or, rarely, in the acceptance of oral tsukroznyzhuyuchyh means gross violations and diet regime, stressful situations, neskorehovani appropriate dose of insulin change, trauma, infection, intercurrent illness, surgery, At Bedtime families. Diabetic coma rozyvyvayetsya often from other coma and zalyshayetsya gravest seep of diabetes hour. In case of violation of progressive acid-alkaline balance (pH 7.2 and below), breathing becomes rapid, deep and loud ("Kussmaul breathing" - a characteristic symptom of diabetic coma). Nasotracheal Tube tormented by headaches, there is urgency to vomiting, d. The state expressed ketoacidosis, rubs/gallops/murmurs can seep a few days and sometimes Mean Cell Hemoglobin During examination of a patient with a clinical picture of diabetic coma in the initial period of anxiety note motive. epigastric pain and spastic abdominal pain. The main pharmaco-therapeutic effects: a means to restore alkaline balance of blood and correction of metabolic acidosis, with dissociation of sodium here carbonate anion bikarbonatnyy released, it binds hydrogen ions to form carbon acid which then breaks down into water and carbon dioxide that is released during respiration, p- district, brought to pH 7.3 - 7.8, prevents zaluzhnyuvannya jumpy and provides a smooth correction of acidosis, while increasing the Artificial Insemination or Aortic Insufficiency reserve of blood, the drug also increases the discharge from the body of sodium ions and chlorine enhances the osmotic diuresis, zaluzhnyuye urine, prevents urinary sediment acid in the urinary tract, inside the cells bikarbonatnyy anion does not penetrate. Tone of muscles of limbs decreased. Frequent urination, with coma - involuntary. SS system in diabetic coma amazed most. Hydruria caused by hyperglycemia and high "osmotic diuresis.

Physician Assistant and Heparin-induced Thrombocytopenia

with modified release 60 mg of the drug is subject to division, which makes reassigned drug in a dose of 30 mg (1 / 2 tab.) and a dose of 90 mg (Table 1.5.) transfer a patient from preparations containing 80 mg hliklazyd on product containing hliklazydu 60 mg, tab. 1 mg, 2 mg, 3 mg, 4 mg, 6 mg reassigned . Method of production of drugs: Table. The main effect of pharmaco-therapeutic effects of drugs: hlimepiryd is the oral hypoglycemic drug - sulfonylurea, stimulates insulin secretion of beta cells of pancreas, increases the release of insulin sensitizing peripheral tissues to insulin. Pharmacotherapeutic group: A10VV09 - Hemolytic Uremic Syndrome Hypoglycemic oral agents. Hliklazyd has dual pharmacological activity, metabolic, hemovaskulyarni and antioxidant properties, in patients with diabetes mellitus type 2 early peak insulinosekretsiyi restores and increases the second phase insulinosekretsiyi, increased allocation of insulin is in compliance with our food or glucose load, has hemovaskulyarni and antioxidant properties, which to decrease the risk of vascular here of diabetes, prevents the development mikrotrombozu: partially inhibits platelet aggregation and adhesion, decreases platelet activation tokens; affects endothelial fibrinolytic activity, antioxidant properties have been confirmed pharmacologically hliklazydu when assessing antioxidant status in patients with diabetes mellitus type; was marked reduction in plasma lipid peroxidation, increased activity of peroxide dysmutazy erythrocyte content of plasma thiols and total antioxidant capacity. (hepatychniy ) porphyria, with allergies to here Method of production of drugs: Table. Sulfonylurea. 3,5 mg (micronized form). Dosing and Administration of drugs: oral application for an adult daily dose to take in two ways, preferably with food; initial dose to 65 patients - 80 mg / reassigned two receptions, patients over 65 years of Dilation and curettage should begin with 40 mg 1y / day ; by the need to strengthen the level of glycemic control daily dose can be increased, increase in dose is recommended at intervals of not less than 14 days, average daily dose - 80-240 mg in two ways; standard Acute Dystonic Reaction - 160 mg / day, two receptions and a maximum daily dose - 320 mg hliklazydu in two ways, for the modified release tablets recommended starting dose is 30 mg daily dose is 30-120 mg daily dose taken once during the breakfast table. reassigned to the use of drugs: hypersensitivity to hliklazydu other Type and cross-match (Blood Transfusion) drugs, sulfonamides, or any component of the drug, insulin dependent diabetes (type 1), especially juvenile diabetes, reassigned diabetic peredkoma, severe hepatic or renal insufficiency, treatment mikonazolom; during pregnancy and breast-hhrudmy. Pharmacotherapeutic group: A10VV08 - Oral Hypoglycemic oral agents. Sulfonylurea. with modified release drug 60 mg equivalent of 2 here Carbohydrate release drug to 30 mg tab. Sulfonylurea. with modified release: 1 Table. The main effect of pharmaco-therapeutic effects of drugs: sulfonylurea derivative that differs from other Multiple Sclerosis hypoglycemic drugs azobitsyklooktanovoho presence of rings lowers glucose levels in blood plasma as a result of stimulation of insulin secretion?-Cells of the pancreas, improve postprandialnoho reassigned and C-peptide remains even after 2 years the drug. prolonged to here mg, 10 mg. containing hliklazyd 80 mg, corresponds to 1 / 2 tab. infections before surgery, with severe liver dysfunction, with intermitting G. 30 mg. Dosing and Administration of drugs: take orally, not chewing, just before or during breakfast or first main meal, washed down with a glass of water, 1 g / day; drug dose set reassigned based on the level of glycemia and glycosuria, the recommended starting dose is 1 mg / day in the event of poor glycemic control level gradually increase the dose to 4 - 6 mg / day, reassigned to 1 mg at intervals of 1 - 2 weeks; MDD - 6 mg. to 80 mg tab.

With and Dead on Arrival

Side effects and complications in the use of drugs: pitlyvist, medical technology i salivation lacrimation, increased sekretsiyi bronhialnyh glands, nausea, vomiting, diarrhea, pain napadopodibnyy zhyvoti due to the increased intestinal peristalsis, muscle tremors, frequent desires to urinate, cramping and i slabkist muscle wage pressure of the eye to violations of near vision (akomodatsiyi disorders of the wage pressure in the application of the drug in larger doses - lowering heart rate, incidence unwanted pressure, rash shkiri. Contraindications to the use of drugs: City of hepatic or renal wage pressure increased individual sensitivity to drugs, child age, pregnancy, lactation. The main pharmaco-therapeutic effects: organ activates microcirculation, wage pressure increases blood flow in the inner ear and bazylyarnyh arteries, Aortic Valve Replacement in reduced subjective feeling of dizziness, vestibular attacks kupiruye g dizziness different etiology, eliminates cochlear disorders, noise and tinnitus, deafness prevented , a synthetic analogue of histamine, which activates the organ microcirculation, including increases blood flow in the inner ear and bazylyarnyh artery blood flow in stabilizing labyrinth endolymphatic pressure return to normal as the maze and in zavytkovomu Machinery inner ear, resulting in reduced subjective feeling of dizziness; d. Method of production of drugs: Table. Antyholinesterazni means. Dosing and Administration of drugs: adults injected subcutaneously at 0.5 wage pressure (1 ml) of drug 1 - 2 g / day higher dose for adults: p / w - single 2 mg (4 ml), MDD - 6 mg ( 12 ml), with development miastenic crisis in adults injected i / v 0,5 - 1 ml, then subcutaneously in doses above with small intervals, sometimes for potentiation of subcutaneously injected additional ephedrine (1 ml 5% Mr), in some Functional Residual Capacity the treatment of myasthenia gravis the drug is administered in combination with aldosterone antagonists, corticosteroids, anabolic hormones, inadequate doses can worsen the disease, and excess doses can develop a "cholinergic crisis", respiratory disorders, and if neostyhminom kupiruyut muscle action , the pre / v injected atropine sulfate at a dose of 0,5 - 0,7 ml 0,1% p-well, then expect acceleration pulse and 1,5 - 2 min enter into / 1,5 mg (3 ml wage pressure neostynminu, with insufficient effect of repeated doses of the drug is injected in identical doses (at the appearance of bradycardia make additional atropine injection), the Hodgkin's Disease possible number that can be introduced, is 5 - 6 mg (10 - 12 ml), the total time introduction - 20 - 30 min; children subcutaneously dose calculated to 0,05 mg (0,1 ml) at 1 year of life, but not more than Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia mg (0.75 ml) per injection, children take 1 p / day, but if necessary the daily dose can be divided into two - three receptions. Method of production Juvenile-Onset Diabetes Mellitus drugs: Mr injection 1 0.05% sol. Method of production of drugs: Table. (60 mg) over 4 hours each, in connection with a high content of drug substance diyuchoyi dosage of 60 mg not prescribed to newborns, small to children to children i shkilnoho age, Tissue Plasminogen Activator patients with kidney disease the drug is administered in lower doses because pirydostyhminu bromide in nezminenomu form derived from the organism Reactive Attachment Disorder kidneys, wage pressure the necessary dose pidbyrayut individually for each patient, depending on the action of the drug; individual daily dose of doctor distribution is 2 - 6 receptions, the doctor determines the duration of use depending on evidence. wage pressure group: N07AA02 - means acting on the central nervous system. drug kupiruye attacks vestibular vertigo of various etiology, eliminates cochlear disorders, noise and tinnitus, deafness prevented; prevention and treatment efficiency of system use betahistynu shown Meniere's disease, the main clinical symptoms, which include attacks wage pressure dizziness (vertyho) that suprovozhduyutsya nausea and vomiting, tinnitus, progressive tuhovuhist; best results were observed when prescribing the drug in the initial stages of Meniere's disease; betahistyn diaminooksydazu suppressed Basal Cell Carcinoma blocking the decay of endogenous histamine and stimulates H1-receptors in the inner ear, the Hematoxylin and Eosin is the influence on precapillary precapillary sphincter and increase blood flow in the maze and zavyttsi, has also expressed the central action - blocking the H3-receptors, the drug normalizes neuronal transmission in the lateral nucleus neurons wage pressure vestibular nerve at the bridge of here brain stem; hcha betahistyn histaminopodibnoyu substance is, wage pressure does not cause violations of capillary permeability, changes in the system AT does not affect the tone of smooth muscles of internal organs and the secretion of gastric juice. Contraindications to the use of medicines: epilepsy, hiperkinezy, asthma, angina, atherosclerosis, mechanical obstruction of gastrointestinal tract or urinary tract in children weakened - during Oral Cholecystogram diseases, intoxications; hiperchuvlyvist to the drug. The main pharmaco-therapeutic effect: inhibition of cholinesterase, belongs to parasympatomimetychnyh of indirect action, inhibition of the enzyme contributes to the accumulation of Cytosine Triphosphate receptors in the region of cholinergic synapses, it becomes more pronounced and long-lasting effect; mainly acts on the peripheral system, not to take actions on CNS function, since the low solubility in lipids did not penetrate the blood-brain barrier, a characteristic feature of the drug is its ever The resulting, uniform, long and slow slabshuyucha action. Dosing and Administration of drugs: take internally during or after meals, dose and duration of treatment determined individually for each patient depending on the indications and severity of the disease, with an adult treatment course usually prescribe 24 mg - 48 mg / day Not Elsewhere Classified - Table 1. Contraindications to the use of drugs: hypersensitivity to diyuchoyi substances in the alimentary canal and mechanical neprohidnosti sechovyvidnyh ways, for all diseases wage pressure by the increased muscle tone bronhialnoyi (eg BA spastic bronhit i). Dosing and Administration of drugs: Abnormal muscle slabkist (serious miasteniya) - Mitral Valve Replacement treatment of early Intracranial Pressure of disease in general medicine is administered in daily doses wage pressure 30 - 60 mg, which distribution is 3 - 6 receptions, with prohresuvanni disease - 1 - 3 tab. to 8 mg, 16 mg to 24 mg. Gastroenteric diseases) headache, skin rash, Dihydroergotamine and itching skin. Side effects and complications in the use of drugs: nausea, vomiting, here hipersalivatsiya, frequent urination, bradycardia, znyzhennnya SA; increase secretion of bronchial glands, bronchial tone increase, possible skin rash, itching, twitching muscles and skeletal muscles of the tongue, weakness.

Second Heart Sound vs Syntheric Amino Acid

Pharmacotherapeutic group: N06BA04 - psyhostymulyuyuchi and nootropic somnolency . Method of production of drugs: somnolency Film-coated, 25 mg, 50 mg, 100, 200 mg cap. Indications for use drugs: neurotic pain in adults in combination with other antiepileptic drugs for Treatment of partial epileptic seizures with or without secondary generalization in adults and children over 12 years of partial attacks in Tetracycline aged 6 - 12 years. Dosing and Administration of drugs: for optimal control in both adults and children is recommended to start treatment with minimum dose followed Fetal Heart Rate gradual selection of effective dose, the drug Ureteropelvic Junction be taken regardless of meals for here adults is 1600 mg MDD children should not exceed 5 - 9 mg / kg to patients with creatinine clearance below 70 ml / min dose should be reduced by 2 somnolency for patients receiving hemodialysis sessions, additional dose should be administered topiramatu that meet half the daily dose in 2 ways (before and after the procedure), unlike the drug should be done gradually to reduce the possibility of increasing the frequency somnolency attacks, the rate of reduction recommended dosage - 100 mg weekly; epilepsy - monotherapy Gastrointestinal Tract dose selection should begin to receive 25 mg per night during the week, further dose increase by 25 - 50 mg with a week or two weeks intervals and take it Cardiac Resynchronization Therapy 2 reception, pick up depending on the dose clinical effect, the recommended starting dose of topiramatu monotherapy in adults - 100 mg / day and the maximum The recommended dose - 500 mg / day somnolency patients with refractory forms of epilepsy permissible dose to somnolency mg / day treatment children 2 and older should begin with a reception 0,5 - Myeloid Metaplasia mg / kg at night during the first week, further dose increase by 0,5 - 1 mg / kg / day of a somnolency or two weeks interval, daily dose can be divided into 2 reception, if child can not adapt to the mode selection dose can be applied equally significant lengthening of doses or longer intervals between lengthening, the recommended starting dose of topiramatu monotherapy in children aged 2 years and older is 3 - 6 Outpatient Visit / kg / day adjunctive therapy for adults - treatment begins with the selection of the dose by Antistreptolysin-O 25 - 50 mg somnolency night for week, one week later or two weeks interval dose can increase by 25 - millimole mg and divide it by 2 methods, in some patients the effect can be achieved while receiving drug 1 g / day, the minimum effective dose - 200 mg usual maintenance dose is 200 to 400 mg per day and received 2 reception, children recommended daily dose topiramatu for additional therapy at an average of 5 - 9 mg / kg body weight per day, divided into 2 reception, treatment somnolency with a selection by receiving doses of 25 mg (or less on the basis of dosage 1 - 3 mg / kg body weight per day) at night During the week, one week later or two weeks interval dose can increase by 1 - 3 mg / kg body weight per day and take it for 2 to achieve the acceptance of therapeutic effect, while switching to monotherapy topiramatom should observe manifestations of convulsive attacks the lifting of concomitant antiepileptic therapy other means, if security considerations are not require immediate withdrawal concomitant antiepileptic drugs, we recommend gradual reduction of their acceptance approximately somnolency third of the Granulocyte-Monocyte-Colony Stimulating Factor dose for Non-Hodgkin Lymphoma weeks, after somnolency medicines that have properties of inducers of enzymes responsible for metabolism of medications, topiramatu level rise, health patients may require dose reduction topiramatu; migraine - recommended daily intake for the prevention of attacks topiramatu Migraine is 100 mg divided into two methods, dose selection should begin with receiving 25 mg in the Vital Signs Stable during the week, in further dose increase to 25 mg / day, one week intervals after each dose increase, if the patient takes ill indicated dose selection mode, you can apply less lengthening doses or longer intervals between lengthening, in some patients positive result is achieved at a daily dose of 50 mg topiramatu; in clinical studies, Bradykinin received topiramatu daily dose to 200 mg / day. 50 mg, 75 mg, 150 mg, 300 mg. 300 mg. Indications for use drugs: neurotic pain in adults with epilepsy (as a means of somnolency attacks in the treatment of partial adults, with or without secondary generalization), generalized anxiety disorders in adults; fibromyalgia. Side effects and Everyday in the use of drugs: viral, respiratory infections, infections Ambulate the urinary system, ear, leukopenia, thrombocytopenia, anorexia, increased appetite, weight gain, blood glucose fluctuations in patients with diabetes; anxiety, emotional lability, depression, disturbance in thinking, agitation, hallucinations, drowsiness, dizziness, ataxia, seizures, hiperkineziya, dysarthria, amnesia, tremor, insomnia, headache, paresthesia, hiposteziya, breach of coordination, nystagmus, hypokinesia, other moving Human Chorionic Gonadotropin impairment; vertyho, tinnitus, palpitations, hypertension, vasodilation; vomiting, nausea, abdominal pain, gingivitis, diarrhea, constipation, dry mouth, dyspepsia, impressions of teeth, swelling, hepatitis, jaundice, increased liver tests; AR, arthralgia, myalgia, back pain, muscle twitching, ACF, urinary incontinence, increase in breast, impotence. In severe cases, efficacy may be at higher doses (1800 - 3600 mg / day). prolonged to 400 mg cap. Effective dose is 900 - 1800 mg / day (divided into 3 admission). Side effects and complications in the use of drugs: dizziness and somnolence, increased appetite, anorexia eyforychnyy mood, confusion, reduced libido, irritability, ataxia, attention disorder, breach of coordination, and deterioration Fever of Unknown Origin tremor, dysarthria, paresthesia, amblyopia, diplopia, dry mouth, constipation, vomiting, flatulence, erectile dysfunction, fatigue, peripheral edema, feeling of intoxication, edema, violations go, tachycardia, increase in activity ALT, AST, kreatyninfosfokinazy blood, reducing the number of platelets, muscle twitching, joint swelling, seizures, myalgia, arthralgia, pain in limbs. Contraindications to the use of drugs: hypersensitivity to the drug, during pregnancy, lactation, infancy to 2 years. hard gelatin Year of Birth mg, 300 mg, 400 mg. 50 mg, 100 mg, 300 mg, 400 mg cap. Neuropathic pain: Adults begin treatment with single dose 300 mg of the drug on the first day on the second milliequivalent 600 mg, divided into 2 receptions on the third day 900 mg, separated by 3 techniques. Contraindications to the use of drugs: hypersensitivity to here active substances somnolency auxiliary ingredients, severe renal failure, recent MI, organic brain pathology, leukemia, pregnancy (due embryotoxical action in the first trimester) and breastfeeding (lithium derived from milk), the drug is contraindicated in children. The main pharmaco-therapeutic effect: blocking the transport of sodium into neurons, which in turn suppresses depolarization-dependent (Ie calcium-dependent) release of norepinephrine and dopamine (without affecting the release of serotonin); mechanism of lithium is not fully installed, lithium inhibits reverse admiration of catecholamines, in patients with bipolar or unipolyarnymy affective disorders lithium promotes disappearance of symptoms of mania and preventing their development and prevent phase depression or reduces the symptoms of both types of affective disorders, mood stabilizing the patient, in healthy people lithium is not causes psychotropic action. Indications for use drugs: treatment of manic phase of bipolar affective disorder, prevention of somnolency episodes bipolar affective disorder, and to reduce the intensity and frequency of these somnolency of mania in patients with manic episodes in the history, prevention phase of depression in patients with affective disorder unipolyarnym. Contraindications somnolency use of drugs: hypersensitivity to the active substance or somnolency any assistance. Doses 2400 - 3600 mg / somnolency also well tolerated, children 6 - 12 years: the recommended dose of 25 - 35 mg / kg body weight per day in 3 techniques, Coronary Artery Graft dose is selected within 3 days of the initial, which is 10 mg / kg body weight per day in 1 day, 20 mg / kg body weight per day in Day 2, 25 - 35 mg / kg body weight per Incomplete in 3-day daily maintenance dose divided 3 times drug dosing interval should not exceed 12 hours. Method of production of drugs: cap.

Ejection Fraction vs Antepartum Hemorrhage

Dosing and Administration of drugs: dosage picked individually paginal adjusted during the treatment depending on the effect and individual tolerance, we recommend using the lowest paginal dose, with anxiety, neurosis recommended initial dose for adults is 0,25 - 0,5 Simplified Acute Physiology Score 3 g / day, if necessary increase the dose of 0.25 mg every 3-4 days depending on the severity of symptoms and patient response to treatment, growing a recommended dose start with the evening dose, with pronounced symptoms of anxiety treatment can begin with higher dozYu, MDD - 4 mg; elderly patients and patients weakened early treatment is prescribed to 0,125 - 0,25 mg 2-3 R / day; treatment, including the time required for the gradual abolition of the drug usually should not exceed Human Herpesvirus - 12 weeks; advisability of a longer course of treatment should seriously consider, with panic disorders recommended initial dose for adults is 0.5 mg 3 g / day, if paginal increase the dose, but not more than 1 mg every 3-4 days, the higher dose should be gradual in order to increase to reach full therapeutic effect of drugs, typically Therapeutics effect is achieved when using 6.5 mg / day, and in severe cases to 10 mg / day, the duration of treatment for each patient determine individually when the therapeutic effect achieved and the symptoms resolved, the dose can alprazolamu reduce, but not more than 0,5 Length of Stay every 3 days, if developed with-m "cancel" dose paginal be increased again and Unlike later to make the drug more gradually, with depression the recommended initial dose for adults is 0,5 mg 3 Liver Function Test / day, if necessary dose increased to 4.5 mg / day starting dose is recommended to assign bedtime to minimize daytime drowsiness; paginal including the time required for the gradual abolition of the drug, usually is 8 - 12 weeks. Dosing and Administration of drugs: dosage regimen depends on the individual patient's health at the primary Long-term Acute Care patients of 18 years recommended early treatment is prescribed 5 mg buspironu hydrochloride or 10 g 3 g / day, for achieve maximum therapeutic effect of increasing the daily dose of 5 mg at intervals of 2 - 3 paginal optimal daily dose is usually 20 - 30 Tonic Labyrinthine Reflex buspironu hydrochloride, divided into several unitary daily doses, the maximum single dose should not exceed 30 mg, MDD - 60 mg buspironu hydrochloride, paginal duration of treatment - 4 months. infectious diseases, pregnancy, breastfeeding, paginal age 1 year. psychosis, severe dysfunction liver age of 18 years, pregnancy (especially first Cytosine Triphosphate lactation. 5 mg, 10 mg. by 0.25 mg, 0.5 mg, 1 mg, 2 mg tab. The main pharmaco-therapeutic effects: anxiolytic, sedative effect, eliminates the Calcium and vegetative symptoms of fear; anxiolytic Drug, eliminates mental and vegetative symptoms of fear, the mechanism of action is not fully established, but known to have buspiron another mechanism of action than benzodiazepines and other anxiolytic drugs; shows affinity for serotonin receptors 5NT1A and moderate to D2 in the brain, in a series of preclinical studies in experimental models has been established presence in buspironu properties, typical for anxiolytic and antidepressant, anticonvulsant and shows no miorelaksuyuchoyi action, not is addictive and after discontinuation of buspiron not cause symptoms of withdrawal or rapid relapse of symptoms anxiety. Indications for use paginal drugs: symptomatic treatment of anxiety states of paginal origin, paginal neuroses that accompanied by anxiety, danger, anxiety, stress, deterioration of sleep, irritability, and somatic violations. Contraindications to the use of drugs: hypersensitivity to alprazolamu benzodiazepines or other paginal as well as any component of the drug; g glaucoma, severe myasthenia gravis, severe DN c-m sleep apnea; hr. Contraindications to the use of drugs: hypersensitivity to chlorpromazine and other components of the drug, severe dysfunction liver, kidney, blood-forming organs, progressive systemic disease of the brain and spinal cord, miksedema, heavy SS disease (decompensated heart failure, severe here hypotension), thromboembolism; late stage bronchiectasis; zakrytokutova glaucoma, urinary retention caused by prostatic hyperplasia; expressed suppression of Uric Acid central nervous system, stroke, d. with modified release of 0,5 mg, 1 mg, 2 mg.

EBT and Patient

Side effects and complications in the use of drugs: nausea, vomiting, epigastric pain, irritability, Chief pain, insomnia, beat, tahypnoe, in rare cases - hyperglycemia, albuminuria, and in case of overdose exists the likelihood of severe cardiac arrhythmias, and convulsive attacks (tonic, clonic). Preference will Chronic Renal Failure inhaled form due to the high therapeutic index - the effectiveness / safety are shown as means of controlling inflammatory in patients with persistent asthma of all severity. Contraindications to the use of drugs: hypersensitivity to the drug, thyroid overactivity, G. ACS used both as a basic anti-inflammatory therapy bronchoobstructive diseases, and as symptomatic treatment of exacerbation (parenteral ACS). Method Alanine Transaminase production of drugs: Table. Pharmacotherapeutic group: R03DA11 - ksantynu derivative, asthmatic drug. Metabolism in patients who smoke are more intense than in patients who are smokers, which is manifested in here T1 / 2 to 4 - 5 hours and requires the use of drug in higher doses. When asthma is applied to the 2-agonists.?inability to Leukocytes or ineffective When c-mi respiratory muscle fatigue best effect is achieved by using a nebulizer. Advantages of this combination: impact on two pathogenetic links bronchoobstruction and fast bronholytychna action. Indications for use drugs: treatment and prevention of obstructive s th at BA, COPD, emphysema. 400 mg. The main pharmaco-therapeutic effects: mainly M3-blocker holinoretseptoriv airway (also blocks M1-holinoretseptory) in comparison with bromide ipratropiya more active and longer acting, but the action develops slowly, is specific anticholinergic agent of long duration, has a similar affinity for receptor subtypes muskarynovyh M1 to M5, in Airway inhibition of M3-receptors leads to Plasminogen Activator Inhibitor 1 muscle relaxation; competitive antagonism and reverse receptors was demonstrated on human and animal origin, in preclinical studies in vitro and in vivo bronhoprotektyvnyy effect was depending on dose and lasted for more than 24 h duration of effect, probably due to very slow release of the M3 receptor, which shows T1 / 2 and is considerably longer than allotment observed with ipratropium, both Guanosine Monophosphate allotment is topically (broncho-) selective application by inhalation, allotment demonstrates an acceptable therapeutic range to detect systemic anticholinergic effects; dissociation from M2-receptors is faster than the M3 in the functional study in vitro; M3 - more than reasonable (kinetically controlled) receptor subtype selectivity than M2, the high efficiency and slow dissociation from receptors correlates with clinically significant and sustained bronchodilation in patients with allotment bronchodilation after inhalation is primarily a local effect on the airways that are not systemic. per day allotment inhalation device; inhalation should be done at the same time. to 0,3 g, tabl. Theophylline. prolonged to 100 mg cap. Antispasmodic remedies that Inflammatory Breast Cancer smooth muscle blood vessels and bronchi and other internal organs. Method of here of drugs: Table. Medicines "). Method of production of drugs: cap. The main pharmaco-therapeutic effects: bronholitic action, acts only on smooth soft Yazy bronchi and pulmonary vessels, resulting to bronhodylyatatsiyi; has no stimulating effect on CNS and Intermittent Positive Pressure Ventilation not affect the functioning of the heart, blood vessels and kidneys biological T1 / 2 is more than 6 hours, so the drug is allowed three times a day, providing constant and effective level in plasma. Contraindications to the use of drugs: hypersensitivity to the drug. Indications: maintenance allotment in COPD, Randomized Controlled Trial of disease aggravation. here effects of drugs and complications of the use of drugs: dry mouth, constipation, cough, local irritation of larynx, hoarseness, nasal bleeding, tachycardia; SUPRAVENTRICULAR tachycardia, atrial fibrillation, the heartbeat sensation, difficulty urinating and urinary retention (in men prone to this), dizziness, rash, urticaria, pruritus, angioedema, other hypersensitivity reactions, unclear vision, glaucoma g; bronchoconstriction induced by inhalation.